Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical…

Overview of attention for article published in Clinical Interventions in Aging, October 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 29 Mendeley

Summary Policy documents X Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia

Article in Vaccine (April 2023)

Immunogenicity profile after COVID-19 vaccination in patients with onco-hematological diseases

Article in Einstein (São Paulo) (March 2023)

Prevention of infections including vaccination strategies in multiple myeloma

Article in American Journal of Hematology (November 2022)